Skip to main content

Table 2 Characteristics of patients with distant metastases at presentation

From: PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome

ID Sex Age (year) Side of primary tumor Histological subtype Vascular invasion Status of surgical margins T parameter N parameter M parameter (site) PSMA expression (%) Recurrence, time in months RAI refractoriness, time in months Status at last follow-up, time in months
#26 F 78 Right Poorly diff Yes Free pT3 pNx/cN0 pM1 (bone) 40 Yes, 12 Yes, 24 months No disease-free, 31
#24 F 79 Left Well diff Yes Free pT2 pN0/cN0 pM1 (bone) 40 Yes, 1 No No disease-free, 37
#51 M 60 Right Well diff No Free pT1 pNx/cN0 pM1 (bone) 40 Yes, 27 Yes, 27 No disease-free, 44
#13 F 71 Right Well diff Yes Involved pT3 pN0/cN0 pM1 (bone)/cM1 (bone, lung) 40 Yes, 6 Yes, 16 No disease-free, 38
#33 M 52 Left Well diff Yes Involved pT1a pNx/cN0 pM1 (bone) 40 Yes, 10 Yes, 32 No disease-free, 53
#45 M 78 Right Well diff Yes Involved pT3 pN0/cN0 pM1 (bone) 70 Yes, 4 Yes, 2 No disease-free, 15
#29 M 47 Right Poorly diff Yes Involved pT4 pN0/cN0 pM1 (bone) 80 Yes, 5 Yes, 5 No disease-free, 6
#57 F 80 Left Poorly diff Yes Free pT3 pN1a/cN1 (mediastinum) cM1 (lung, liver) 80 Yes, 5 Yes, 3 No disease-free, 26
#36 F 76 Right Well diff Yes Free pT3 pNx/cN0 pM1(bone) 80 Yes, 13 Yes, 5 No disease-free, 87